Home
Rx

Basic Information

Subcategory & Sub-subcategory

Trade Type

Sell

Product Name

Taterdin

Registered Market

Specifications

  • Dosage Form: Tablet film-coated
  • Packaging: Box 2 blister x 10 tablet, box 3 blister x 10 tablet; box 1 vial x 30 tablet, box 1 vial x 60 tablet, box 1 vial x 100 tablet, vial plastic or vial glass
  • Strength: 600mg
  • Standards: In-house standard
  • Shelf Life: 36 month

Documents

Drug Marketing Authorization Number
Document No.: 893200133000
Issue Date: Nov 18, 2024
Expiry Date: Nov 18, 2029
Note: 783/QĐ-QLD | 213
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product